The life sciences sector has been gripped by a mergers and acquisition frenzy, and it looks set to continue. But what does it mean for the industry?
Bid raised to $15.8 billion in cash after rival offer from Irish firm
Companies expect $500m in savings through ‘R&D rationalisation’
© Royal Society of Chemistry Registered charity number: 207890
Site powered by Webvision Cloud